Summit Global Investments »

Vir Biotechnology shares owned by Summit Global Investments

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $355k 35k 10.19

More positions owned by Summit Global Investments

RBB Sgi Enha Mkt Etf (LDRX)
RBB Sgi Enha Core Et (USDX)
RBB Sgi Us Large Cap (SGLC)
RBB Sgi Diversi Tac (DYTA)
RBB Sgi Enh Nasd Etf (QXQ)
RBB Sgi Enhanced Glb (GINX)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Tesla Motors (TSLA)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Eli Lilly & Co. (LLY)

View all positions for Summit Global Investments

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Vanguard Portfolio Management
Sb Investment Advisers
GSK
State Street Corporation
Vanguard Capital Management
Point72 Asset Management
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
ADAR1 Capital Management
Goldman Sachs Group
FMR
Nuveen

View all funds holding Vir Biotechnology